[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100468120":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":29,"centralContacts":33,"locations":39,"responsibleParty":87,"collaborators":91,"id":95,"slug":96,"hasResults":97,"nctId":98,"briefTitle":99,"officialTitle":99,"acronym":18,"eligibilityCriteria":100,"healthyVolunteers":97,"sex":101,"minAge":102,"maxAge":18,"enrollmentInfo":103,"targetDuration":18,"studyType":106,"phases":107,"briefSummary":109,"conditions":110,"keywords":114,"overallStatus":42,"whyStopped":18,"lastUpdateSubmitDate":115,"lastUpdatePostDateStruct":116,"startDateStruct":119,"completionDateStruct":121,"leadSponsor":123,"locationsCount":124},{"fullName":5,"class":6},"Dana-Farber Cancer Institute","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm B (informational video)","EXPERIMENTAL","Participants will complete screening questionnaire via text or by phone to establish baseline awareness and interest in clinical trials and then randomized to the SURGE intervention where they will receive:\n\n* Informational Video",[13],"Behavioral: SURGE",{"label":15,"type":16,"description":17,"interventionNames":18},"Arm A (standard of care)","NO_INTERVENTION","Participants will complete screening questionnaire via text or by phone to establish baseline awareness and interest in clinical trials and then randomized to Standard of Care (SOC) and receive:\n\n* Standard of Care",null,{"label":20,"type":10,"description":21,"interventionNames":22},"Arm C (informational video and patient navigation)","Participants will complete screening questionnaire via text or by phone to establish baseline awareness and interest in clinical trials and then randomized to the SURGE intervention where they will receive:\n\n* Informational Video and Patient Navigation",[13],[24],{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":18},"BEHAVIORAL","SURGE","Video with or without person to person guidance to support decision making around genetic testing",[9,20],[30],{"name":31,"affiliation":5,"role":32},"Nadine J McCleary, MD MPH","PRINCIPAL_INVESTIGATOR",[34,38],{"name":31,"role":35,"phone":36,"phoneExt":18,"email":37},"CONTACT","(617) 632-6729","nj_mccleary@dfci.harvard.edu",{"name":31,"role":35,"phone":36,"phoneExt":18,"email":18},[40,58,72],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Dana Farber Cancer Institute","RECRUITING","Boston","Massachusetts","02215","United States","US",{"type":49,"coordinates":50},"Point",[51,52],-71.05977,42.35843,{"lat":52,"lon":51},[55,57],{"name":56,"role":35,"phone":36,"phoneExt":18,"email":37},"Nadine J. McCleary, MD, MPH",{"name":56,"role":32,"phone":18,"phoneExt":18,"email":18},{"facility":59,"status":42,"city":60,"state":44,"zip":61,"country":46,"countryCode":47,"cosmosGeoPoint":62,"geoPoint":66,"contacts":67},"Dana-Farber Cancer Institute at St. Elizabeth's Medical Center","Brighton","02135",{"type":49,"coordinates":63},[64,65],-71.15644,42.3501,{"lat":65,"lon":64},[68,71],{"name":69,"role":35,"phone":18,"phoneExt":18,"email":70},"Olga Kozyreva, MD","olga_kozyreva@dfci.harvard.edu",{"name":69,"role":32,"phone":18,"phoneExt":18,"email":18},{"facility":73,"status":74,"city":75,"state":44,"zip":76,"country":46,"countryCode":47,"cosmosGeoPoint":77,"geoPoint":81,"contacts":82},"Dana-Farber Cancer Instiute - Merrimack Valley","NOT_YET_RECRUITING","Methuen","01844",{"type":49,"coordinates":78},[79,80],-71.19089,42.7262,{"lat":80,"lon":79},[83,86],{"name":84,"role":35,"phone":18,"phoneExt":18,"email":85},"Pedro Sanz-Altamira, MD","pedro_sanz-altamira@dfci.harvard.edu",{"name":84,"role":32,"phone":18,"phoneExt":18,"email":18},{"type":88,"investigatorFullName":89,"investigatorTitle":90,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"SPONSOR_INVESTIGATOR","Nadine McCleary, MD, MPH","Sponsor-Investigator",[92],{"name":93,"class":94},"Bristol-Myers Squibb","INDUSTRY","100468120","surge-supporting-underrepresented-minorities-in-genomics-based-cancer-trial-enrollment-intervention-100468120",false,"NCT05375643","SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)","Inclusion Criteria:\n\n* Adult (age 18 years or older)\n* Black, Latinx, OR older adult (age 70 years or older)\n* Scheduled for a new patient consultation\n* Suspected or confirmed advanced malignancy (requiring active treatment)\n* Gastrointestinal, hematologic, or thoracic cancer\n* DFCI patient at Longwood\u002FChestnut Hill, DFCI satellite at St. Elizabeth's Medical Center, or DFCI satellite at Merrimack Valley\n\nExclusion Criteria:\n\n* Malignancy or former malignancy that requires only surveillance\n* Not continuing care at a participating DFCI site\n* Speaks a language other than English or Spanish\n* Unable to provide consent","ALL","18 Years",{"count":104,"type":105},210,"ESTIMATED","INTERVENTIONAL",[108],"NA","SURGE aims to increase equity in clinical trial enrollment by addressing barriers to genomic testing, which is increasingly needed to assess precision clinical trial eligibility and access standard precision therapies. The study is an interventional pilot meant primarily to assess the feasibility of the intervention. The intervention is comprised of a patient navigator, text message questionnaire, and informational video.",[111,112,113],"Gastrointestinal Cancer","Hematologic Cancer","Thoracic Cancer",[111,112,113],"2025-11-04",{"date":117,"type":118},"2025-11-05","ACTUAL",{"date":120,"type":118},"2023-04-03",{"date":122,"type":105},"2028-07-30",{"name":89,"class":6},3]